Alexandra Jane Scott

Dr. Alexandra Jane Scott

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2017 in Nature Genetics
Verified
Journal Article
Open access
PDF file
GCGTEx Consortium
GTEx Consortium
CCColby Chiang
Colby Chiang
ASAlexandra Jane Scott
Alexandra Jane Scott
JDJoe R Davis
Joe R Davis
ETEmily K Tsang
Emily K Tsang
IHIra M Hall
Ira M Hall
Ira Hall, Donald Conrad, the GTEx consortium and colleagues identify 23,602 high-confidence structural variants (SVs) and 24,884 cis expression quantitative trait loci (eQTLs) across 13 human tissues. They estimate that SVs are the causal variant at 3.5–6.8% of eQTLs and identify 789 SVs predicted to directly alter gene expression, most of which are noncoding variants in regulatory elements. Structural variants (SVs) are an important source of human genetic diversity, but their contribution to traits, disease and gene regulation remains unclear. We mapped cis expression quantitative trait loci (eQTLs) in 13 tissues via joint analysis of SVs, single-nucleotide variants (SNVs) and short insertion/deletion (indel) variants from deep whole-genome sequencing (WGS). We estimated that SVs are causal at 3.5–6.8% of eQTLs—a substantially higher fraction than prior estimates—and that expression-altering SVs have larger effect sizes than do SNVs and indels. We identified 789 putative causal SVs predicted to directly alter gene expression: most (88.3%) were noncoding variants enriched at enhancers and other regulatory elements, and 52 were linked to genome-wide association study loci. We observed a notable abundance of rare high-impact SVs associated with aberrant expression of nearby genes. These results suggest that comprehensive WGS-based SV analyses will increase the power of common- and rare-variant association studies.

12 February 2012 in Bioinformatics
Verified
Journal Article
Open access
PDF file
MWMartin Wu
Martin Wu
ASAlexandra Jane Scott
Alexandra Jane Scott
Summary: With the explosive growth of bacterial and archaeal sequence data, large-scale phylogenetic analyses present both opportunities and challenges. Here we describe AMPHORA2, an automated phylogenomic inference tool that can be used for high-throughput, high-quality genome tree reconstruction and metagenomic phylotyping. Compared with its predecessor, AMPHORA2 has several major enhancements and new functions: it has a greatly expanded phylogenetic marker database and can analyze both bacterial and archaeal sequences; it incorporates probability-based sequence alignment masks that improve the phylogenetic accuracy; it can analyze DNA as well as protein sequences and is more sensitive in marker identification; finally, it is over 100× faster in metagenomic phylotyping. Availability:http://wolbachia.biology.virginia.edu/WuLab/Software.html. Contact:mw4yv@virginia.edu Supplementary information: Supplementary data are available at Bioinformatics online.

1 March 2019 in Cell
Verified
Journal Article
Closed access
TLTuuli Lappalainen
Tuuli Lappalainen
ASAlexandra Jane Scott
Alexandra Jane Scott
MBMargot Brandt
Margot Brandt
IHIra M. Hall
Ira M. Hall

12 October 2017 in Nature
Verified
Journal Article
Open access
PDF file
XLXin Li
Xin Li
YKYungil Kim
Yungil Kim
ETEmily K. Tsang
Emily K. Tsang
JDJoe R. Davis
Joe R. Davis
FDFarhan N. Damani
Farhan N. Damani
SMStephen B. Montgomery
Stephen B. Montgomery
Rare genetic variants are abundant in humans and are expected to contribute to individual disease risk1,2,3,4. While genetic association studies have successfully identified common genetic variants associated with susceptibility, these studies are not practical for identifying rare variants1,5. Efforts to distinguish pathogenic variants from benign rare variants have leveraged the genetic code to identify deleterious protein-coding alleles1,6,7, but no analogous code exists for non-coding variants. Therefore, ascertaining which rare variants have phenotypic effects remains a major challenge. Rare non-coding variants have been associated with extreme gene expression in studies using single tissues8,9,10,11, but their effects across tissues are unknown. Here we identify gene expression outliers, or individuals showing extreme expression levels for a particular gene, across 44 human tissues by using combined analyses of whole genomes and multi-tissue RNA-sequencing data from the Genotype-Tissue Expression (GTEx) project v6p release12. We find that 58% of underexpression and 28% of overexpression outliers have nearby conserved rare variants compared to 8% of non-outliers. Additionally, we developed RIVER (RNA-informed variant effect on regulation), a Bayesian statistical model that incorporates expression data to predict a regulatory effect for rare variants with higher accuracy than models using genomic annotations alone. Overall, we demonstrate that rare variants contribute to large gene expression changes across tissues and provide an integrative method for interpretation of rare variants in individual genomes.

1 May 2021 in Cell
Verified
Journal Article
Closed access
OGOlivia M de Goede
Olivia M de Goede
DNDaniel C Nachun
Daniel C Nachun
NFNicole M Ferraro
Nicole M Ferraro
MGMichael J Gloudemans
Michael J Gloudemans
ARAbhiram S Rao
Abhiram S Rao
SMStephen B Montgomery
Stephen B Montgomery

11 September 2020 in Science
Verified
Journal Article
Closed access
NFNicole M. Ferraro
Nicole M. Ferraro
BSBenjamin J. Strober
Benjamin J. Strober
JEJonah Einson
Jonah Einson
NANathan S. Abell
Nathan S. Abell
FAFrancois Aguet
Francois Aguet
ABAlexis Battle
Alexis Battle
Outliers in the human transcriptome reveal the functional effects of rare genetic variants.